Montelukast Teva (Montelukast Sodium)

Montelukast Sodium is a selective antagonist of the cysteinyl leukotriene receptor CysLT1. By blocking this receptor, it prevents leukotriene D4 from causing bronchoconstriction, mucus secretion, and inflammatory cell recruitment, thereby improving airway patency and reducing allergic symptoms.

The dosage of Montelukast Teva is determined by the prescribing healthcare professional based on the patient’s age, weight, and specific indication. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for Montelukast during pregnancy are limited, so it should only be used if the potential benefit justifies the potential risk. Breastfeeding mothers should consult their physician, as the drug is excreted in breast milk and the effects on the infant are not fully known.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids and long‑acting beta‑agonists. It is particularly useful for patients with allergic components or those who need an adjunct therapy, but it does not replace rescue bronchodilators for acute attacks.

Montelukast Teva should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and potency.

Montelukast Teva is taken orally, usually as a tablet, with or without food. The exact administration instructions, including timing relative to meals, are provided by the prescribing clinician.

Serious risks, though rare, include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, hepatic injury, anaphylaxis, and neuropsychiatric events like depression or suicidal thoughts. Patients should seek immediate medical attention if any of these symptoms develop.

Montelukast Teva is contraindicated in individuals with known hypersensitivity to montelukast or any of its excipients. Patients with a history of severe allergic reactions or those who have experienced serious adverse events with leukotriene antagonists should avoid its use.